International Clinical Research Center

Join GCEA for 5th International Clinical Engineering & HTM Congress in Visakhapatnam, India

Retrieved on: 
Thursday, September 7, 2023

Arlington, Virginia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Are you interested in promoting international cooperation in clinical engineering and healthcare technology management?

Key Points: 
  • Arlington, Virginia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Are you interested in promoting international cooperation in clinical engineering and healthcare technology management?
  • The Association for the Advancement of Medical Instrumentation (AAMI) is collaborating with the Global Clinical Engineering Alliance (GCEA) to bring clinical engineering experts from around the world together to collaborate and share their knowledge.
  • The 5th International Clinical Engineering & Health Technology Management Congress (ICEHTMC) will be held in Visakhapatnam, India from November 10 - 13, 2023, and will focus on the lifecycle of medical devices and lessons learned from the COVID-19 pandemic.
  • GCEA interim president Yadin David stated, “Healthcare is a local issue, but the technology that supports the delivery of healthcare services is international.

The Shriners Hospitals for Children - Canada Research Centre celebrates half a century of existence

Retrieved on: 
Thursday, August 17, 2023

So research into mineralized tissue has always been a strength in Quebec," explains Professor René St-Arnaud, PhD, Director of the Research Center.

Key Points: 
  • So research into mineralized tissue has always been a strength in Quebec," explains Professor René St-Arnaud, PhD, Director of the Research Center.
  • In 1973, following the integration of Shriners Hospitals for Children – Canada into the Quebec health care network, Shriners Children’s management, with the approval of the provincial government, created the first Research Centre within its hospital network.
  • The Shriners Hospital for Children - Canada Research Centre is constantly developing new ways to care for children.
  • To mark this 50th anniversary at Shriners Hospital for Children – Canada, Dr. St-Arnaud hosted a scientific seminar yesterday featuring a number of prestigious speakers.

The Yacht Club of Monaco Celebrates the 70th Anniversary with a Packed Programme of Festivities

Retrieved on: 
Wednesday, January 11, 2023

MONACO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- January kicks off a busy events programme for 2023, as the Yacht Club de Monaco celebrates 70 years since it was set up by Prince Rainier III.

Key Points: 
  • MONACO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- January kicks off a busy events programme for 2023, as the Yacht Club de Monaco celebrates 70 years since it was set up by Prince Rainier III.
  • Presided since 1984 by HSH Prince Albert II of Monaco, this private club continues to honour its public service remit by organising world class events to promote the destination.
  • L’Art de Vivre la Mer is the motto of the Yacht Club de Monaco.
  • This edition also celebrates the 100th anniversary of the birth of Prince Rainier III, who founded YCM in 1953 and was so passionate about the sea and boats.

Brooks Rehabilitation Ranked Number One in Florida on Newsweek's "America's Best Physical Rehabilitation Centers 2022" List

Retrieved on: 
Wednesday, October 12, 2022

They are honored that their high-quality care was recognized on Newsweek's "America's Best Physical Rehabilitation Centers 2022" list.

Key Points: 
  • They are honored that their high-quality care was recognized on Newsweek's "America's Best Physical Rehabilitation Centers 2022" list.
  • Brooks Rehabilitation Hospital was ranked the number one facility in Florida.
  • Doug Baer, Brooks Rehabilitation President & CEO, said, "Brooks is known for our exceptional patient outcomes, cutting-edge technology and world-class clinical research.
  • For more than 50 years, the nonprofit Brooks Rehabilitation has been a comprehensive, complete system of care for physical rehabilitation.

Brooks Rehabilitation participates in national stroke recovery trial using breakthrough technology

Retrieved on: 
Thursday, September 22, 2022

JACKSONVILLE, Fla., Sept. 22, 2022 /PRNewswire/ -- Brooks Rehabilitation's first participant in the national stroke recovery trial, EMAGINE, has just completed study participation.

Key Points: 
  • JACKSONVILLE, Fla., Sept. 22, 2022 /PRNewswire/ -- Brooks Rehabilitation's first participant in the national stroke recovery trial, EMAGINE, has just completed study participation.
  • The EMAGINE stroke recovery trial will enroll 150 randomized subjects nationwide 4-21 days following a stroke.
  • For more than 50 years, Brooks Rehabilitation, headquartered in Jacksonville, Fla., has been a comprehensive source for physical rehabilitation services.
  • BrainQ, the EMAGINE Stroke Recovery Trial sponsor, is a US and Israel-based company pioneering a novel therapy for reducing disability and maximizing the recovery potential for stroke and other neurodisorder victims.

Brooks Rehabilitation Continues Growth in Central Florida, Plans to Add New and Expanded Outpatient Clinics at Least through 2024

Retrieved on: 
Monday, August 8, 2022

ORLANDO, Fla. and JACKSONVILLE, Fla., Aug. 8, 2022 /PRNewswire/ -- As part of its continued growth and community commitment to Orlando/Central Florida, Brooks Rehabilitation anticipates opening and expanding its outpatient clinics in the market through at least 2024. Brooks had five locations in the Orlando area in January 2022, and it anticipates growing to 11 clinics locally by January 2023. Brooks is also exploring all sub-markets of Orlando for future growth.

Key Points: 
  • Brooks' newest location, in Clermont, is scheduled to open in early September and will provide tri-disciplinary outpatient services of PT, OT and SLP.
  • "There is a tremendous need in the Central Florida market for immediate access to quality outpatient rehabilitation services," said Tom Langer, PT, CSCS, Brooks Rehabilitation outpatient regional director, Orlando.
  • For more than 50 years, Brooks Rehabilitation, headquartered in Jacksonville, Fla., has been a comprehensive source for physical rehabilitation services.
  • For more than 50 years, Brooks Rehabilitation, headquartered in Jacksonville, Fla., has been a comprehensive source for physical rehabilitation services.

Brooks Rehabilitation Opens Additional Inpatient Rehabilitation Hospital

Retrieved on: 
Wednesday, April 20, 2022

JACKSONVILLE, Fla., April 20, 2022 /PRNewswire/ -- Brooks Rehabilitation is now welcoming patients to its new 60-bed, state-of-the-art inpatient rehabilitation hospital. The additional 76,056 sq. ft. hospital is located on its existing 115-acre campus in the Bartram Park area of Jacksonville, Fla.

Key Points: 
  • JACKSONVILLE, Fla., April 20, 2022 /PRNewswire/ -- Brooks Rehabilitation is now welcoming patients to its new 60-bed, state-of-the-art inpatient rehabilitation hospital.
  • ft. hospital is located on its existing 115-acre campus in the Bartram Park area of Jacksonville, Fla.
    Brooks Rehabilitation is now welcoming patients to its new 60-bed, state-of-the-art inpatient rehabilitation hospital.
  • Brooks Rehabilitation Hospital Bartram Campus joins Brooks' two existing rehabilitation hospitals to meet the demands of a growing population .The original 160-bed rehabilitation hospital on University Blvd.
  • Brooks also manages a 40-bed inpatient rehabilitation hospital in partnership with Halifax Health in Daytona Beach, Fla.
    Frontline staff members were actively involved in the design of the new Bartram hospital.

Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID

Retrieved on: 
Monday, December 20, 2021

FORT COLLINS, Colo., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today the enrollment and randomization of the first patient, with several more in screening for an initial study to evaluate STAT-205 as a potential treatment to mitigate SARS-CoV-2 progression, the virus that causes COVID-19. STAT-205 is an immune-modulator designed to decrease elevated inflammatory responses associated with cytokine production and modulate the Th1/Th2 helper cells to control immune dysfunction.

Key Points: 
  • Now that vaccines are widely available, developing safe and effective treatments for people who contract COVID-19 is our next challenge.
  • I am excited that our site has randomized the first patient in the clinical trial of STAT-205.
  • The study is designed to assess the pharmacokinetics (PK), early predictive biomarkers, and safety of STAT-205.
  • Statera has clinicalprograms for Crohns disease (STAT-201),hematology (Entolimod), pancreatic cancer (STAT-401) andCOVID-19 (STAT-205) in addition to potential expansion into fibromyalgia and multiple sclerosis.To learn more about Statera Biopharma, please visit www.staterabiopharma.com .

World Economic Forum Grants AgroAmerica the New Champions Award

Retrieved on: 
Wednesday, November 10, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211110006209/en/
    AgroAmericas Human Development Center project received the New Champions Award 2021 endorsed by the World Economic Forum in the category of Excellence in Social Responsibility.
  • A project built in 10ha of land donated by AgroAmerica for the construction of a Medical Clinic, Research Center and school for workers children in Southwestern Guatemala.
  • World Economic Forum New Champion companies are dynamic high-growth companies that are championing new business models, emerging technologies, and sustainable growth strategies in the Fourth Industrial Revolution.
  • See World Economic Forums New Champions award announcement here .

Marshfield Clinic Research Institute Joins TriNetX to Increase Participation in High-Impact Clinical Trial Opportunities

Retrieved on: 
Monday, July 26, 2021

CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural patient population.

Key Points: 
  • CAMBRIDGE, Mass., July 26, 2021 /PRNewswire/ -- The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural patient population.
  • "Marshfield Clinic Research Institute is a leader in clinical trials and research," said Dr. Narayana S. Murali, Executive Director of Marshfield Clinic, Inc. "Being part of the TriNetX network increases our opportunities to participate in high-impact studies and bring the best care to our patients.
  • The Marshfield Clinic Research Institute supports and oversees clinical trials of drugs, devices, and biotechnology conducted at the Marshfield campus and at Marshfield Clinic's regional centers.
  • "Marshfield selected TriNetX as a platform to increase our collaboration with pharmaceutical companies," said Dr. Robert Haws, Director of the Clinical Research Center at the Research Institute.